29 Atrial Fibrillation Clinical Trials in New York, NY (2026)

Q: Are there atrial fibrillation clinical trials in New York?

Yes, there are 29 atrial fibrillation clinical trials currently recruiting in New York, NY.

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Q: Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Atrial Fibrillation Studies in New York

NCT05723926Recruiting

Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

Patients with atrial fibrillation (AF) who have had a prior stroke are at very high risk of recurrent ischemic stroke. About 40% of these strokes are due to large emboli which result in large cerebral...

New York, NYNA2,000 participantsJavelin Medical

View Study Details

NCT06486636Recruiting

Pericardiotomy in Cardiac Surgery

PRINCE is an international, multicentre, randomized controlled trial of posterior pericardiotomy in patients without a history of atrial fibrillation (AF) or flutter undergoing cardiac surgery....

New York, NYNA1,400 participantsPopulation Health Research Institute

View Study Details

NCT07485738Recruiting

The Relationship Between Blood Flow Readings During Surgery and How Well the Graft Stays Open and How Patients Recover Afterward in Coronary Artery Bypass Graft Surgery

The purpose of this study is to learn more about a tool called Transit-Time Flow Measurement (TTFM). TTFM uses sound waves during surgery to check how well blood is flowing through blood vessels. This...

New York, NYNA1,242 participantsWeill Medical College of Cornell University

View Study Details

NCT06957366Recruiting

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

PAUSE 2 study is a prospective, open-label, blinded-endpoint non-inferiority RCT of PAUSE vs. ASRA management in DOAC treated high risk patients with AF/VTE who need elective high bleed risk surgery/p...

New York, NYNA920 participantsMcMaster University

View Study Details

NCT06578104Recruiting

PULSED AF Post-Approval Study

PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months....

New York, NY580 participantsMedtronic Cardiac Ablation Solutions

View Study Details

NCT06772493Recruiting

ViewFlex X ICE First-in-Human Study

This prospective, acute, first-in-human, non-significant risk study is intended to evaluate a modified version of the ViewFlex X ICE Catheter, Sensor Enabled (ViewFlex X SE) and ViewMate Multi Ultraso...

New York, NY500 participantsAbbott Medical Devices

View Study Details

NCT07523750Recruiting

A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

The purpose of this study is to assess how safe VARIPULSE pulsed field ablation (PFA) catheter is and how well it works compared to food and drug administration (FDA) approved FARAWAVE PFA catheter in...

New York, NYNA466 participantsBiosense Webster, Inc.

View Study Details

NCT06099730Recruiting

Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF

The primary objective of this clinical investigation is to demonstrate the safety and 12-month effectiveness of pulmonary vein isolation (PVI) and posterior LA wall isolation in the treatment of subje...

New York, NYNA442 participantsMassachusetts General Hospital

View Study Details

NCT06056271Recruiting

Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

Observational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems dur...

New York, NY400 participantsVolta Medical

View Study Details

NCT07535268Recruiting

REPRESENT-PF Registry

This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority pa...

New York, NY275 participantsVivek Reddy

View Study Details

NCT03168659Recruiting

CardioFocus HeartLight Post-Approval Study

This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivota...

New York, NYNA250 participantsCardioFocus

View Study Details

NCT05988411Recruiting

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

This is a Prospective, controlled, single-blind, randomized (2:1, Intervention:Control) clinical trial. The purpose of the study is to determine the role of adjunctive renal sympathetic denervation in...

New York, NYNA250 participantsVivek Reddy

View Study Details

NCT05810220Recruiting

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate differe...

New York, NYNA200 participantsNYU Langone Health

View Study Details

NCT05203302Recruiting

Novel Coding Strategies for Children With Cochlear Implants

The purpose of this study is to understand performance with a cochlear implant. The long-term goals of this research are to improve sound perception with cochlear implants and to better understand the...

New York, NYNA190 participantsNYU Langone Health

View Study Details

NCT07217067Recruiting

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

A randomized, placebo-controlled, participant-and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden as well as the safety, tolerability and pharmacokinetics of...

New York, NYPHASE2165 participantsNovartis Pharmaceuticals

View Study Details

NCT06938412Recruiting

Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation

Atrial fibrillation (AF) affects 1 in 4 individuals during their lifetime and continues to increase in frequency and impact. Exercise intervention has established benefits to improve AF symptoms and b...

New York, NYNA120 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06936566Recruiting

MAGIC Ruxolitinib for aGVHD

This clinical trial will study ruxolitinib-based treatment of acute graft-versus-host-disease (GVHD) that developed following allogeneic hematopoietic cell transplant. Acute GVHD occurs when donor cel...

New York, NYPHASE298 participantsJohn Levine

View Study Details

NCT05996627Recruiting

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

This phase II trial compares the effect of belumosudil to a placebo in treating patients with chronic graft versus host disease. Chronic graft versus host disease remains a major complication of stem ...

New York, NYPHASE282 participantsFred Hutchinson Cancer Center

View Study Details

NCT06747091Recruiting

ARIADNE Clinical Trial

A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter...

New York, NYNA60 participantsStavros E Mountantonakis

View Study Details

NCT07124078Recruiting

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

This study will be conducted to compare Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy....

New York, NYPHASE260 participantsIncyte Corporation

View Study Details

NCT06961630Recruiting

Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction

The goal of this pilot study is to assess enrollment feasibility of a randomized trial of direct oral anticoagulant and high-intensity statin therapy versus usual care in patients with Myocardial Inju...

New York, NYEARLY_PHASE150 participantsNYU Langone Health

View Study Details

NCT07638995Recruiting

Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction

The study aims to evaluate the following: 1) the incidence of new onset atrial fibrillation in patients with an atrial leadless pacemaker, 2) the need for upgrade from a standalone atrial leadless pac...

New York, NY50 participantsNorthwell Health

View Study Details

NCT07006506Recruiting

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

The purpose of this study is to find out whether adding belumosudil to a usual approach for reducing the risk of graft-versus-host disease (GVHD) may be an effective GVHD prevention approach for peopl...

New York, NYPHASE246 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05675930Recruiting

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

The purpose of this study is to find out whether photobiomodulation/PBM therapy using the Thor LX2.3 therapy system is a safe and effective treatment for oral Graft-Versus-Host Disease/GVHD....

New York, NYPHASE244 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07116031Recruiting

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

This is an open-label, single group, Phase 1/2, 1-arm study for treatment of children aged 1 to \<18 years with active moderate-to-severe cGVHD that is refractory to or recurred after at least 2 prior...

New York, NYPHASE237 participantsSanofi

View Study Details

NCT06569082Recruiting

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

The proposed trial is a single arm, non-randomized, single center pilot study utilizing CliniMACS CD34 Reagent System for patients following allogeneic hematopoietic stem cell transplant (HSCT) requir...

New York, NYNA21 participantsNYU Langone Health

View Study Details

NCT05642455Recruiting

SPEARHEAD-3 Pediatric Study

This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers....

New York, NYPHASE120 participantsAdaptimmune

View Study Details

NCT07494019Recruiting

Community Safety and Violence

This study will describe, estimate, and explore the effectiveness of community-centered safety models (CCSMs)-including co-response, alternative response, and community violence intervention modalitie...

New York, NY15 participantsNYU Langone Health

View Study Details

NCT07278869Recruiting

Applause Study I - Append System Early Feasibility Study

This early feasibility study is intended to evaluate the safety and feasibility of the Append System for eliminating the left atrial appendage (LAA) through a transcatheter procedure that invaginates ...

New York, NYNA15 participantsAppend Medical Ltd.

View Study Details

About Atrial Fibrillation Clinical Trials in New York

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 29 atrial fibrillation clinical trials recruiting participants in New York, NY. These studies are seeking a combined 9,998 participants. Research is being sponsored by Javelin Medical, Population Health Research Institute, Weill Medical College of Cornell University and 20 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in New York — FAQ

Are there atrial fibrillation clinical trials in New York?

Yes, there are 29 atrial fibrillation clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 29 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated July 16, 2026 from ClinicalTrials.gov